- Home
- SND vs SNTI Comparison
SND vs SNTI Comparison
Compare SND & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SND
- SNTI
- Stock Information
- Founded
- SND 2011
- SNTI 2016
- Country
- SND United States
- SNTI United States
- Employees
- SND N/A
- SNTI N/A
- Industry
- SND Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- SND Industrials
- SNTI Health Care
- Exchange
- SND Nasdaq
- SNTI Nasdaq
- Market Cap
- SND 78.9M
- SNTI 85.3M
- IPO Year
- SND 2016
- SNTI N/A
- Fundamental
- Price
- SND $1.91
- SNTI $3.15
- Analyst Decision
- SND Hold
- SNTI Strong Buy
- Analyst Count
- SND 1
- SNTI 1
- Target Price
- SND $2.25
- SNTI $12.00
- AVG Volume (30 Days)
- SND 147.8K
- SNTI 25.6K
- Earning Date
- SND 05-13-2025
- SNTI 05-06-2025
- Dividend Yield
- SND 5.25%
- SNTI N/A
- EPS Growth
- SND N/A
- SNTI N/A
- EPS
- SND N/A
- SNTI N/A
- Revenue
- SND $293,878,000.00
- SNTI N/A
- Revenue This Year
- SND N/A
- SNTI N/A
- Revenue Next Year
- SND N/A
- SNTI N/A
- P/E Ratio
- SND N/A
- SNTI N/A
- Revenue Growth
- SND N/A
- SNTI N/A
- 52 Week Low
- SND $1.73
- SNTI $1.52
- 52 Week High
- SND $2.80
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- SND 46.80
- SNTI 43.94
- Support Level
- SND $1.78
- SNTI $3.03
- Resistance Level
- SND $2.20
- SNTI $3.25
- Average True Range (ATR)
- SND 0.08
- SNTI 0.20
- MACD
- SND 0.01
- SNTI 0.00
- Stochastic Oscillator
- SND 40.44
- SNTI 17.02
About SND Smart Sand Inc.
Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.